Donor bone marrow infusions are tolerogenic in human renal transplantation

被引：4
|
作者：
Ciancio, G
Garcia-Morales, R
Mathew, J
Carreno, M
Burke, GW
Ricordi, C
Kenyon, N
Esquenazi, V
Cirocco, R
Tzakis, A
Miller, J
机构：
[1] Univ Miami, Sch Med, Div Transplantat, Dept Surg,Diabet Res Inst, Miami, FL 33101 USA
[2] Miami Vet Affairs Med Ctr, Miami, FL USA
来源：
TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 1-2期
关键词：
D O I：
10.1016/S0041-1345(00)02485-4
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：1295 / 1296
页数：2
相关论文
共 50 条
  • [21] Successful hair transplantation from a bone marrow transplantation donor to a bone marrow transplantation recipient
    Hwang, Sungjoo Tommy''
    Kim, Hyojin
    Lee, Weon Ju
    Kim, Do Won
    Kim, Jung Chul
    Kook, Hoon
    Lee, Je Jung
    DERMATOLOGIC SURGERY, 2007, 33 (02) : 236 - 238
  • [22] LYMPHOCYTE-T DEPLETION OF DONOR BONE-MARROW IN HUMAN-BONE MARROW TRANSPLANTATION
    GORDONSMITH, E
    BRITISH JOURNAL OF CANCER, 1985, 52 (04) : 650 - 650
  • [23] Toxicity and efficacy of 409 donor lymphocyte infusions for treatment of relapse after allogeneic bone marrow transplantation
    Raiola, AM
    Van Lint, MT
    Lamparelli, T
    Gualandi, F
    Di Grazia, C
    Dominietto, A
    Romagnani, C
    Berisso, G
    Bregante, S
    Vassallo, F
    Frassoni, F
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 2001, 27 : S127 - S127
  • [24] Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation
    A Bacigalupo
    M Soracco
    F Vassallo
    M Abate
    MT Van Lint
    F Gualandi
    T Lamparelli
    D Occhini
    N Mordini
    S Bregante
    O Figari
    F Benvenuto
    M Sessarego
    G Fugazza
    P Carlier
    M Valbonesi
    Bone Marrow Transplantation, 1997, 19 : 927 - 932
  • [25] Donor lymphocyte infusions after allogeneic bone marrow transplantation for thalassaemia: a single-centre experience
    Karasu, G.
    Uygun, V.
    Kazik, M.
    Kupesiz, A.
    Kurt, P.
    Ozturk, Z.
    Hazar, V.
    Yesilipek, A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S233 - S233
  • [26] Donor leukocyte infusions for treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation
    Fores, R
    DiezMartin, JL
    Briz, M
    Cabrera, JR
    Sanjuan, I
    Regidor, C
    GarciaTalavera, J
    Fernandez, MN
    BONE MARROW TRANSPLANTATION, 1996, 17 (03) : 439 - 441
  • [27] Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation
    Bacigalupo, A
    Soracco, M
    Vassallo, F
    Abate, M
    VanLint, MT
    Gualandi, F
    Lamparelli, T
    Occhini, D
    Mordini, N
    Bregante, S
    Figari, O
    Benvenuto, F
    Sessarego, M
    Fugazza, G
    Carlier, P
    Valbonesi, M
    BONE MARROW TRANSPLANTATION, 1997, 19 (09) : 927 - 932
  • [28] Functional and phenotypical analysis of donor lymphocyte infusions used in patients undergoing allogeneic bone marrow transplantation
    Schaefer, A. -K.
    Waterhouse, M.
    Follo, M.
    Duyster, J.
    Bertz, H.
    Finke, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 60 - 60
  • [29] Donor leukocyte infusions (DLI) to treat leukemia relapse after allogeneic bone marrow transplantation (aloBMT).
    Reynoso, EE
    Guevara, AG
    Miranda, E
    Salinas, V
    Acosta, A
    Sobrevilla, PJ
    BLOOD, 1995, 86 (10) : 3835 - 3835
  • [30] Unrelated donor bone marrow transplantation for bone marrow failure.
    Elebute, M
    Marsh, JCW
    Ball, SE
    Gordon-Smith, EC
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 58 - 58
12345